ECM
WVE icon

ExodusPoint Capital Management’s Wave Life Sciences WVE Stock Holding History

ExodusPoint Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-94,080
Closed -$689K – 2135
2025
Q3 		$689K Buy
94,080
+83,816
+817% +$678K 0.01% 1084
2025
Q2 		$67K Sell
10,264
-86,004
-89% -$568K ﹤0.01% 1368
2025
Q1 		$778K Buy
+96,268
New +$1.05M 0.01% 988
2021
Q4 		– Sell
-18,381
Closed -$90K – 2653
2021
Q3 		$90K Sell
18,381
-48,797
-73% -$296K ﹤0.01% 1919
2021
Q2 		$447K Buy
+67,178
New +$439K ﹤0.01% 1516
2021
Q1 		– Sell
-36,793
Closed -$290K – 2675
2020
Q4 		$290K Sell
36,793
-64,994
-64% -$546K ﹤0.01% 1557
2020
Q3 		$864K Buy
101,787
+55,024
+118% +$603K 0.02% 749
2020
Q2 		$487K Buy
+46,763
New +$440K 0.01% 1101
2019
Q3 		– Sell
-18,650
Closed -$487K – 1681
2019
Q2 		$487K Buy
+18,650
New +$523K 0.02% 488

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

ExodusPoint Capital Management's WVE Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 94,080 shares — an estimated $689K sold.

ExodusPoint Capital Management first reported a position in WVE in Q2 2019 and held it in 9 quarters. The position peaked at $864K in Q3 2020. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • ExodusPoint Capital Management reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 94,080 Wave Life Sciences shares in Q4 2025, an estimated $689K.
  • ExodusPoint Capital Management first reported a position in Wave Life Sciences in Q2 2019 and held it in 9 quarters.
  • ExodusPoint Capital Management's Wave Life Sciences position peaked at $864K in Q3 2020.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.